maculardiseasefoundation.org
GenVec
http://www.maculardiseasefoundation.org//articles/genvec.htm
Macular Disease Foundation,. P O Box 2334, Va Beach, VA 23450. Dry and Wet AMD. Genvec Begins Phase 1 Clinical Trial of Gene Therapy in Patients with Age-Related Macular Degenartion. Treatment Designed to Prevent Vision Loss. By Tom Hoglund, Originally published in Update, Winter 2003 Issue. The GenVec treatment uses gene therapy to treat the eye with the gene that encodes pigment epithelium-derived factor (PEDF). Expressed in retinal pigment epithelial cells that line the retina, PEDF's protein prod...
ceezad.org
CEEZAD - Partners
http://ceezad.org/partners/industry.html
White papers and Proposals. Http:/ www.akonni.com/. Http:/ www.artelis.be/. Boehringer Ingelheim Vetmedica Inc. Http:/ www.genvec.com/. Http:/ www.fishersci.com/. Http:/ www.hemispherx.net/. INT (Integrated Nano Tech.). Http:/ www.integratednano.com/. Http:/ www.lab-leipzig.de/. Http:/ www.lah.de/. Http:/ www.merial.com/. Midwest Vet. Services, Inc. Http:/ www.nadefa.org/. Http:/ www.orionbiosciences.com/. Http:/ www.prionics.com/. Http:/ www.qiagen.com/. Http:/ www.rexanimalhealth.com/. July 23, 2016.
tech.uchicago.edu
Start-Ups | UChicagoTech
http://tech.uchicago.edu/portfolio/startups
UChicagoTech - Center for Technology Development and Ventures. UChicago Researchers and Innovators. UChicago Researchers and Innovators. Report a New Discovery (Forms and Policies). Publicly Traded Companies Developed by UChicagoTech or ARCH Development. Companies Developed by UChicagoTech or ARCH Development. Acquired by Haemonetics) (HAE). Aviron (acquired by MedImmune. Acquired by McGraw-Hill) (MHP). Acquired by McGraw-Hill) (MHP). Hyseq (now part of Nuvelo now a part of Arca Biopharma.
biotech-in-spain.blogspot.com
Biotech in Spain / Biotecnología en España: mayo 2007
http://biotech-in-spain.blogspot.com/2007_05_01_archive.html
Biotech in Spain / Biotecnología en España. Welcome to Biotech in Spain! A place to share and comment on biotech business and investment. ¡Bienvenidos a Biotecnología en España! Un espacio para compartir y comentar sobre el negocio de la biotecnología e inversión. Ver todo mi perfil. Domingo, 6 de mayo de 2007. La internacionalización de las empresas biotecnológicas españolas, el único camino. Nuestras mejores empresas biotecnológicas lo saben y lo cumplen. Con gran alegría he visto en Biospace. El objet...
archventure.com
ARCH Venture Partners - providing venture capital funds for information technology, life sciences, and physical sciences firms
http://www.archventure.com/port_ls_bio.html
San Francisco, CA. Therapeutics for combating the increasing bacterial resistance to antibiotics. Small molecule drug development. Acquired by Global Publicly-traded Biopharmaceutical Company. Acquired by Cubist Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. Cancer therapies addressing cellular metabolism. Enhanced potency, tolerability and pharmacology of protein based therapeutics. Alnylam Holdings, Inc. Array BioPharma, Inc. Chemical intermediate sales and chemistry outsourcing. Mountain View, CA.
SOCIAL ENGAGEMENT